Cerebral vein thrombosis in a four year old with Behçet's disease

Duygu Ovunc Hacihamdioglu1, Murat Demiriz2, Gungor Sobaci3

  • 1Gulhane Military Medical Academy, Medicine School, Department of Pediatrics, Division of Pediatric Nephrology and Rheumatology, Turkey.

Reumatologia Clinica
|January 7, 2014
PubMed

Insights

This study presents the youngest case of Behçet's disease (BD) with sagittal sinus thrombosis in a four-year-old child. Infliximab therapy showed promise for treating this rare pediatric neurological complication.

Area of Science:

  • Vascular Medicine
  • Pediatric Neurology
  • Rheumatology

Background:

  • Behçet's disease (BD) is a multisystemic inflammatory disorder characterized by vasculitis affecting various blood vessels.
  • Central nervous system (CNS) involvement occurs in 5-10% of BD patients, with neurological symptoms typically appearing after 3-6 years of disease onset.
  • Pediatric BD, though rare, can lead to increased morbidity and mortality, with a mean age of onset around 7 years.

Observation:

  • A four-year-old Turkish boy, the youngest reported case, presented with Behçet's disease and sagittal sinus thrombosis.
  • The patient exhibited papilledema but no overt neurological signs at presentation.
  • This case highlights an unusual early presentation of neurological involvement in pediatric BD.

Findings:

  • Treatment with infliximab was initiated for the sagittal sinus thrombosis in this pediatric BD patient.
  • Initial response to infliximab suggests potential efficacy in managing this severe complication.
  • The patient's presentation represents the earliest documented instance of sagittal sinus thrombosis in childhood Behçet's disease.

Implications:

  • Infliximab may represent a viable therapeutic option for refractory sagittal sinus thrombosis in pediatric Behçet's disease.
  • This case expands the understanding of the clinical spectrum and early manifestations of CNS involvement in childhood BD.
  • Further long-term studies are warranted to confirm the sustained efficacy and safety of infliximab in this population.

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469